Skip to main content

Physician Resources

Find a Doctor CME Refer Your Patient

Recently Added |Browse All Content

Cerebral Aneurysms Podcast

Cerebral Aneurysms

Who is at risk, what causes a hemorrhage in the brain, and from a medical standpoint, what are the newest findings about cerebrovascular aneurysms? Join us as our experts discuss latest treatments, what to look out for and more on this ...

Investigating Dramatic Radiation Dose Reduction For HPV-Related Head and Neck Cancers News

Investigating Dramatic Radiation Dose Reduction For HPV-Related Head and Neck Cancers

In continuing efforts to develop effective treatments with less impact on quality of life, Miami Cancer Institute is participating in a clinical trial to reduce by more than half the radiation dosage for head and neck cancers related to ...

 Anthony Miniaci, M.D., joins Baptist Health as the Deputy Chief Medical Executive of Baptist Health Orthopedic Care News

Anthony Miniaci, M.D., joins Baptist Health as the Deputy Chief Medical Executive of Baptist Health Orthopedic Care

Anthony Miniaci, M.D., a world-renown orthopedic surgeon, joins Baptist Health as the deputy chief medical executive of Baptist Health Orthopedic Care.

Total Shoulder Arthroplasty with a Nonspherical Humeral Implant and an Inlay Glenoid Video

Total Shoulder Arthroplasty with a Nonspherical Humeral Implant and an Inlay Glenoid

Watch a Total Shoulder Arthroplasty with a Nonspherical Humeral Implant and an Inlay Glenoid with Dr. Anthony Miniaci and Dr. John Zvijac with Baptist Health Orthopedic Care.

Cancer Rehabilitation: A Look at its Importance Throughout the Oncology Care Continuum Podcast

Cancer Rehabilitation: A Look at its Importance Throughout the Oncology Care Continuum

Join Miami Cancer Institute experts, Adrian Cristian, M.D., chief of cancer rehabilitation, and Romer Orada M.D., a physical medicine and rehabilitation physician, as they discuss the importance of cancer rehabilitation.

New Trojan Horse in Oncology: Antibody­ Drug Conjugate Offers Promise in Treatment of HER2-Low Breast Cancer News

New Trojan Horse in Oncology: Antibody­ Drug Conjugate Offers Promise in Treatment of HER2-Low Breast Cancer

In a presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, Reshma Mahtani, DO, chief of breast oncology at Miami Cancer Institute, part of Baptist Health South Florida, described ADCs as the "new Trojan horses in oncology."

Baptist Health News

There are no recent posts available.